National Biotechnology Initiative Act of 2025

# National Biotechnology Initiative Act of 2025 (HR 2756) - Summary **What the Bill Would Do** The National Biotechnology Initiative Act of 2025 would establish a coordinated federal program to advance biotechnology research and development in the United States. While the bill's specific provisions aren't detailed in the available information, such initiatives typically aim to support scientific research, foster innovation in genetic engineering and biological sciences, and potentially strengthen American competitiveness in biotechnology industries. **Who It Affects** This legislation would primarily affect research institutions, universities, biotechnology companies, and federal agencies involved in scientific research. It could also indirectly impact patients who might benefit from new medical treatments developed through advanced biotechnology, as well as the broader U.S.

economy and job market in the biotech sector. **Current Status** As of now, HR 2756 is in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. The bill was sponsored by Representative Stephanie Bice (R-Oklahoma). For more detailed information about the specific provisions and funding mechanisms, interested parties would need to consult the full legislative text.